Global Issues in Comparing Vaccination Strategies - PowerPoint PPT Presentation

About This Presentation
Title:

Global Issues in Comparing Vaccination Strategies

Description:

Estimates of current disease burden for vaccine-preventable diseases ... Burkina Faso, Kenya, Tanzania, Laos, Zambia, Rwanda. Costing studies completed. Ghana ... – PowerPoint PPT presentation

Number of Views:66
Avg rating:3.0/5.0
Slides: 28
Provided by: larajw
Category:

less

Transcript and Presenter's Notes

Title: Global Issues in Comparing Vaccination Strategies


1
Global Issues in Comparing Vaccination Strategies
Dr Lara Wolfson Vaccine Assessment
Monitoring Department of Immunization, Vaccines
Biologicals
2
Vaccination Strategies WHO
  • Overview of work at WHO
  • Examples of current work
  • Unmet needs

3
Measuring Mortality and Morbidity
  • Estimates of current disease burden for
    vaccine-preventable diseases
  • Forecasts of future disease burden
    cost-effectiveness under different vaccination
    scenarios
  • Methods and Materials to assist ROs and
    countries in estimation and forecasting of
    disease burden, introduction of new vaccines,
    cost-effectiveness assessments
  • Support to users of burden of disease data,
    technical assistance for cost-effectiveness

4
Estimating (Total) Mortality at WHO
Life tables
5
Vaccine-Preventable Diseases 24
6
Causes of 4.1 M Child Deaths, 2002
7
Proportional Mortality Approaches
8
Natural History Approaches
9
Looking at all the sources of data
Method 1
Best estimate
Method 3
Method 2
10
General Approach
  • Get best data/information (literature/grey
    literature review)
  • Primary data
  • Secondary data
  • Seek expert advise/opinion
  • natural history of the disease
  • methods/models
  • context
  • Develop consultative process with ROs/countries
  • Develop best methods/models
  • Use best assumptions/probabilities
  • Conduct sensitivity analysis
  • Validate/check consistency coherence
  • Document (explicit transparent)
  • Subject to in-house review, then expert review

11
Expected Outputs
  • Burden of Disease Estimates
  • By country, age group, sex, year
  • With estimates of uncertainty, document methods
  • Country consultation, continuous update of inputs
    (?!?)
  • "Scenarios" (aka Comparing Strategies)
  • Recommendations for best practice
  • Tools for use at country level
  • Provide support to advocacy efforts
  • Cost-Effectiveness
  • Tools and guidelines, training, support

12
Publish methods, database Of results,
inputs Country clearance
HQ produces burden of disease estimates
Simultaneous
Update annually
Develop scenario models And database of inputs
Develop costing tools and guidelines
Publish tools
Country Requests CEA assistance
Targeted Country for Field-testing or Evaluation
Publish tools
IF!
Collaborate with country On CEA
13
GAVI and the Vaccine Fund
  • 75 out of 192 member states with GNI lt1000
    eligible for support
  • Immunization Systems Strengthening (ISS) support
    performance/reward based system
  • New Vaccine Support (NVS) vaccine provided for
    1st five years
  • "Next Window" 2005-2009
  • ICF (Investment Case Framework)

14
The ADIP Paradigm
15
The Example Measles
  • Need to develop a method for estimating measles
    mortality and morbidity
  • Measure progress towards Measles Mortality
    Reduction Goal (50 reduction in measles deaths
    from 1999-2005)
  • Evaluate the impact of supplemental immunization
    activities (SIAs) and routine coverage
  • Develop a tool for countries to use to estimate
    their own disease burden and monitor progress

16
"Current" Burden of Measles
17
CFR Literature Review
18
869,000 in 1999 to 610,000 in 2002
19
Measles Comparing Vaccination Strategies in 35
African Countries, 2005-2015
20
SIR Model for 192 Member States
21
How to calculate R0?
22
Looking at Scenarios
23
(No Transcript)
24
Work that is needed (urgently!!)
  • High Priority/Some Work Started
  • Pneumococcal Disease (Meningitis, Pneumonia)
  • Rotavirus
  • Yellow Fever
  • Rubella/CRS
  • Diphtheria
  • Lower Priority/Not Started
  • Meningoccocus A/C
  • Japanese Encephalitis
  • Mumps
  • Dengue
  • Typhoid
  • Cholera
  • ETEC
  • Papillomavirus
  • RSV
  • Shigella
  • Streptococcus group A
  • Infant TB

25
CEA
26
Data Collected by the Global Monitoring System
(VAM)
27
Mixed Bag of Needs
  • Simple tools for use in country to make policy
    decisions but validated compared to complex
    methods.
  • Valid assessments of current burden of disease
    (MDG!!)
  • Guidance on plugging "data holes"
  • Introduction of new vaccines
Write a Comment
User Comments (0)
About PowerShow.com